A Phase 1 Trial of SGN-CD33A As Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia (AML)
暂无分享,去创建一个
F. Ravandi | D. DeAngelo | J. Lancet | A. Fathi | A. Advani | T. Kovacsovics | R. Walter | H. Erba | D. Bixby | S. Faderl | E. Stein | A. Stein | A. Jillella | M. O'Meara | Baiteng Zhao